Molecule
Compounded orforglipron
1 recorded program. No comparable monthly price is verified. See the record for advertised amounts and conditions.
US route An FDA-approved orforglipron product exists, but a compounded preparation is not itself an FDA-approved product. FDA does not review compounded drugs for safety, effectiveness or quality before marketing. A molecule listing does not establish whether an individual preparation meets applicable requirements. Classification recorded October 2026. FDA source. FDA information on compounded GLP-1 drugs. All orforglipron forms.
Entries
More columns to the right? Scroll across the table to see all details.
| Entry | Provider | Form | Recorded price with its payment basis | Last verified | Link |
|---|---|---|---|---|---|
| EntryTR-1206Not verified | ProviderMochi Health | FormOral · preparation details unconfirmed | Recorded price$31 | Last verifiedNovember 2026 | Record |
Historical recorded price · November 2026 · not currently verified Published figure · Compounded orforglipron — advertised starting amountInitial payment not verified The renewal charge is not verified. The compounded oral catalog advertises a starting amount; selected dose, supply, payment interval and full invoice are unconfirmed. Medication and membership are separate; individual eligibility and state availability remain unconfirmed. | |||||